A case of transient right ventricular failure secondary to severe pulmonary hypertension in setting of methamphetamine use

P. Kaur, Syed S. Fatmi, Sidra Shakil, Saikiran Mandyam, Bsmah Abdalslam
{"title":"A case of transient right ventricular failure secondary to severe pulmonary hypertension in setting of methamphetamine use","authors":"P. Kaur, Syed S. Fatmi, Sidra Shakil, Saikiran Mandyam, Bsmah Abdalslam","doi":"10.5348/100013c03pk2022cr","DOIUrl":null,"url":null,"abstract":"\n Methamphetamine has been documented to be associated with pulmonary hypertension. Past studies have shown the association of methamphetamine abuse with pulmonary hypertension; however, cases of isolated acute to subacute right heart failure secondary to methamphetamine use have not been documented. Acute to subacute right heart failure, secondary to methamphetamine use itself represents a diagnostic challenge as there is no specific protocol in place for evaluation for pulmonary hypertension secondary to methamphetamine use and high degree of suspicion is needed to differentiate it from other cardio-pulmonary conditions. Echocardiographic findings of increased right ventricular systolic pressure along with morphological findings suggesting cardiac remodeling in the setting of methamphetamine use is highly suspicious of acute to subacute right heart failure. Early recognition and management, along with long-term abstinence from methamphetamine use is critical to prevent chronic effects on myocardium and to prevent further cardiac remodeling. Although dedicated cardiothoracic imaging and cardiac catheterization can be beneficial; neither of these modalities are needed to establish the diagnosis and to initiate primary interventions. Computed tomography (CT) scan however would be beneficial in excluding other causes of pulmonary hypertension, such as primary pulmonary conditions and pulmonary embolism.\n","PeriodicalId":144865,"journal":{"name":"Edorium Journal of Cardiology","volume":"07 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Edorium Journal of Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5348/100013c03pk2022cr","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Methamphetamine has been documented to be associated with pulmonary hypertension. Past studies have shown the association of methamphetamine abuse with pulmonary hypertension; however, cases of isolated acute to subacute right heart failure secondary to methamphetamine use have not been documented. Acute to subacute right heart failure, secondary to methamphetamine use itself represents a diagnostic challenge as there is no specific protocol in place for evaluation for pulmonary hypertension secondary to methamphetamine use and high degree of suspicion is needed to differentiate it from other cardio-pulmonary conditions. Echocardiographic findings of increased right ventricular systolic pressure along with morphological findings suggesting cardiac remodeling in the setting of methamphetamine use is highly suspicious of acute to subacute right heart failure. Early recognition and management, along with long-term abstinence from methamphetamine use is critical to prevent chronic effects on myocardium and to prevent further cardiac remodeling. Although dedicated cardiothoracic imaging and cardiac catheterization can be beneficial; neither of these modalities are needed to establish the diagnosis and to initiate primary interventions. Computed tomography (CT) scan however would be beneficial in excluding other causes of pulmonary hypertension, such as primary pulmonary conditions and pulmonary embolism.
甲基苯丙胺使用后继发于严重肺动脉高压的短暂性右心室衰竭1例
甲基苯丙胺已被证实与肺动脉高压有关。过去的研究表明,甲基苯丙胺滥用与肺动脉高压有关;然而,孤立的急性至亚急性右心衰继发于甲基苯丙胺的病例尚未被记录。甲基苯丙胺使用引起的急性至亚急性右心衰本身是一项诊断挑战,因为目前尚无评估甲基苯丙胺使用引起的肺动脉高压的具体方案,需要高度怀疑才能将其与其他心肺疾病区分开来。超声心动图结果显示右心室收缩压升高以及形态学结果提示甲基苯丙胺使用背景下的心脏重构,高度怀疑急性至亚急性右心衰。早期识别和管理,以及长期戒除甲基苯丙胺的使用对于防止心肌的慢性影响和防止进一步的心脏重塑至关重要。虽然专门的心胸造影和心导管检查是有益的;这两种方式都不需要用于诊断和启动初级干预措施。然而,计算机断层扫描(CT)有助于排除肺动脉高压的其他原因,如原发性肺部疾病和肺栓塞。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信